The milestone comes shortly after the 100th Prodisc C Vivo case in October and the first Prodisc C SK case in November, according to a news release. Both devices use the Prodisc CORE technology.
Centinel Spine’s total disc replacement devices have met significant milestones in 2022. In July, three Centinel Spine cervical disc replacement implants recieved FDA pre-market approval.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
